Engineering a HER2specific antibodydrug conjugate to increase lysosomal delivery and therapeutic efficacy httpsgo.nature.com2YGIRz2Âpic.twitter.comyj0U3z6TsU
Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy https://go.nature.com/2YGIRz2 pic.twitter.com/yj0U3z6TsU
More From BioPortfolio on "Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy https://go.nature.com/2YGIRz2 pic.twitter.com/yj0U3z6TsU"